PT2185197T - Novas composições de solução contendo fator celular e sua utilização para o tratamento de feridas - Google Patents

Novas composições de solução contendo fator celular e sua utilização para o tratamento de feridas

Info

Publication number
PT2185197T
PT2185197T PT08827981T PT08827981T PT2185197T PT 2185197 T PT2185197 T PT 2185197T PT 08827981 T PT08827981 T PT 08827981T PT 08827981 T PT08827981 T PT 08827981T PT 2185197 T PT2185197 T PT 2185197T
Authority
PT
Portugal
Prior art keywords
containing solution
treating wounds
solution compositions
cellular factor
novel cellular
Prior art date
Application number
PT08827981T
Other languages
English (en)
Inventor
S Marshall Vivienne
A Smith Charlotte
J Trumpower Catherine
L Sing George
O Palladino Linda
Original Assignee
Noveome Biotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noveome Biotherapeutics Inc filed Critical Noveome Biotherapeutics Inc
Publication of PT2185197T publication Critical patent/PT2185197T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1891—Angiogenesic factors; Angiogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
PT08827981T 2007-08-22 2008-08-08 Novas composições de solução contendo fator celular e sua utilização para o tratamento de feridas PT2185197T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96570707P 2007-08-22 2007-08-22
US12596008P 2008-04-30 2008-04-30

Publications (1)

Publication Number Publication Date
PT2185197T true PT2185197T (pt) 2019-01-21

Family

ID=40378434

Family Applications (1)

Application Number Title Priority Date Filing Date
PT08827981T PT2185197T (pt) 2007-08-22 2008-08-08 Novas composições de solução contendo fator celular e sua utilização para o tratamento de feridas

Country Status (11)

Country Link
US (11) US20090054339A1 (pt)
EP (1) EP2185197B1 (pt)
JP (1) JP2010536851A (pt)
CN (2) CN104623669A (pt)
CA (1) CA2696877A1 (pt)
CY (1) CY1120994T1 (pt)
DK (1) DK2185197T3 (pt)
ES (1) ES2702809T3 (pt)
PT (1) PT2185197T (pt)
TR (1) TR201815580T4 (pt)
WO (1) WO2009025730A1 (pt)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080084808A (ko) * 2005-11-17 2008-09-19 바이오미메틱 세라퓨틱스, 인크. ｒｈＰＤＧＦ-ＢＢ 및 생체적합성 매트릭스를 사용하는상악안면골 보강
ES2443581T3 (es) * 2006-02-09 2014-02-19 Biomimetic Therapeutics, Llc Composiciones y métodos para el tratamiento de hueso
US9161967B2 (en) * 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
US20100151025A1 (en) * 2007-02-20 2010-06-17 Biomimetic Therapeutics, Inc. Prevention and treatment for osteonecrosis and osteoradionecrosis of the jaw
US20100129328A1 (en) * 2007-07-24 2010-05-27 Sing George L Methods for promoting hair growth
US20090054339A1 (en) * 2007-08-22 2009-02-26 Marshall Vivienne S Novel cellular factor-containing solution compositions
EP2567692B1 (en) 2008-02-27 2016-04-06 Biomet Biologics, LLC Use of a device for obtaining interleukin-1 receptor antagonist rich solutions
US9480549B2 (en) 2008-04-25 2016-11-01 Allosource Multi-layer tissue patches
US9358320B2 (en) 2008-04-25 2016-06-07 Allosource Multi-layer tissue patches
JP2012519556A (ja) * 2009-03-05 2012-08-30 バイオミメティック セラピューティクス， インコーポレイテッド 骨軟骨欠損を治療するための血小板由来増殖因子組成物および方法
US20100239539A1 (en) * 2009-03-23 2010-09-23 Sing George L Methods for promoting differentiation and differentiation efficiency
BR112012020566B1 (pt) 2010-02-22 2021-09-21 Biomimetic Therapeutics, Llc Composição de fator de crescimento derivado de plaqueta
US8313764B2 (en) 2010-06-22 2012-11-20 Stemnion, Inc. Wound healing device
US20120046601A1 (en) * 2010-08-23 2012-02-23 Sing George L Methods for delivering novel cell and cell-based compositions
US20130302262A1 (en) * 2010-12-20 2013-11-14 Stemnion, Inc. Methods for treating dental diseases, disorders and injuries
US8642547B2 (en) * 2011-01-10 2014-02-04 Stemnion, Inc. Methods for accelerating the healing of connective tissue injuries and disorders
ES2647471T3 (es) * 2011-01-18 2017-12-21 Noveome Biotherapeutics, Inc. Dispositivo y procedimiento para la curación de heridas
MX2014000567A (es) * 2011-07-15 2014-05-01 Anthrogenesis Corp Tratamiento de lesion por radiacion utilizando celulas adherentes derivadas del amnios.
US9162011B2 (en) 2011-12-19 2015-10-20 Allosource Flowable matrix compositions and methods
US20150133381A1 (en) * 2012-05-16 2015-05-14 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods for the diagnosis and the treatment of familial thoracic aortic aneurysms caused by tgfb2 loss of function mutations
US8980251B2 (en) * 2013-02-23 2015-03-17 Stemnion, Inc. Methods for preventing and treating hemorrhoids
US20140242040A1 (en) * 2013-02-23 2014-08-28 Stemnion, Inc. Methods for preventing and/or treating nasal polyps and rhinosinusitis
US20140242043A1 (en) * 2013-02-23 2014-08-28 Stemnion, Inc. Methods for preventing or treating optic neuritis
US9186379B2 (en) * 2013-02-23 2015-11-17 Stemnion, Inc. Methods for preventing or treating necrotizing enterocolitis
AU2014248873B2 (en) 2013-03-13 2017-03-23 Allosource Fascia fibrous compositions and methods for their use and manufacture
ES2821658T3 (es) 2013-03-13 2021-04-27 Noveome Biotherapeutics Inc Dispositivo médico que tiene un revestimiento que comprende ACCS
US9486485B2 (en) * 2013-03-15 2016-11-08 Stemnion, Inc. Methods for treating urushiol-induced contact dermatitis
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
CA2899713C (en) 2013-03-15 2022-07-19 Allosource Cell repopulated collagen matrix for soft tissue repair and regeneration
US9314487B2 (en) 2013-05-17 2016-04-19 Stemnion, Inc. Methods for treating cartilage disorders, diseases, and injuries
US20150051147A1 (en) * 2013-08-19 2015-02-19 Stemnion, Inc. Methods for treating hidradenitis suppurativa
US9636364B2 (en) 2013-12-04 2017-05-02 Stemnion, Inc. Methods for treating ocular contusion and blunt injury and traumatic injury to the optic nerve
KR102161901B1 (ko) 2013-12-06 2020-10-05 알로소스 조직의 시트를 건조하는 방법
US20150335712A1 (en) 2014-05-21 2015-11-26 Stemnion, Inc. Treatment of Diseases and Conditions Caused by Increased Vascular Permeability
PL3865563T3 (pl) 2014-11-25 2024-01-29 Corning Incorporated Materiały i sposoby do przedłużania pożywki do hodowli komórkowej
US10213284B2 (en) 2015-06-30 2019-02-26 Tela Bio, Inc. Corner-lock stitch patterns
WO2017015421A1 (en) 2015-07-21 2017-01-26 Tela Bio, Inc. Compliance control stitching in substrate materials
JP2018525360A (ja) 2015-07-22 2018-09-06 テンプル ユニヴァーシティ − オブ ザ コモンウェルス システム オブ ハイアー エデュケーション 創傷治癒、組織工学、及び再生医療のための組成物及び方法における使用のための大豆由来の生物活性ペプチド
EP3448308B1 (en) 2016-04-26 2024-08-14 Tela Bio, Inc. Hernia repair grafts having anti-adhesion barriers
US10772986B2 (en) 2017-01-26 2020-09-15 Allosource Fascia fibrous compositions and methods for their use and manufacture
US20180271914A1 (en) * 2017-03-21 2018-09-27 Noveome Biotherapeutics, Inc. Methods for Reducing the Extent of Light-induced Tissue Inflammation and Injury
CN110831694A (zh) * 2017-03-31 2020-02-21 细尔琳生物医学公司 生物相容性调整细胞培养基组合物及其用途
KR102018609B1 (ko) * 2017-04-26 2019-09-06 이장호 중간엽 줄기세포 배양액을 포함하는 세포 또는 조직의 동결보존용 조성물
EP3761963B1 (en) 2018-03-09 2025-01-22 Tela Bio, Inc. Surgical repair graft
US11446130B2 (en) 2019-03-08 2022-09-20 Tela Bio, Inc. Textured medical textiles
US10881693B2 (en) 2019-04-09 2021-01-05 Combangio, Inc. Processes for making and using a mesenchymal stem cell derived secretome
WO2021207282A2 (en) 2020-04-07 2021-10-14 Combangio, Inc. Lyophilized mesenchymal stem cell derived secretome and uses thereof

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874746A (en) * 1987-12-22 1989-10-17 Institute Of Molecular Biology, Inc. Wound headling composition of TGF-alpha and PDGF
GB8803697D0 (en) * 1988-02-17 1988-03-16 Deltanine Research Ltd Clinical developments using amniotic membrane cells
DE4216341A1 (de) * 1992-05-16 1993-11-18 Roehm Gmbh Lichtstreuende Polymethacrylat-Formkörper mit hohen Temperatur- und Wetterechtheitswerten
US20030191061A1 (en) * 1994-03-31 2003-10-09 Brewitt Barbara A. Treatment methods using homeopathic preparations of growth factors
US20020192198A1 (en) * 1998-04-21 2002-12-19 Elia James P. Method for growing human organs and suborgans
JPH0912478A (ja) * 1995-04-25 1997-01-14 Fuji Yakuhin Kogyo Kk 新規な皮膚欠損症治療剤
US5612026A (en) 1996-01-25 1997-03-18 The Procter & Gamble Company Cholesterol lowering drink mix compositons
JP2000508922A (ja) * 1996-04-26 2000-07-18 ケース ウエスターン リザーブ ユニバーシティ 間葉幹細胞を用いる皮膚再生
US6393647B1 (en) * 2000-02-17 2002-05-28 The Libman Company Broom with mounting bracket for detachable handle
US7429378B2 (en) * 2003-05-13 2008-09-30 Depuy Spine, Inc. Transdiscal administration of high affinity anti-MMP inhibitors
GB2408207A (en) * 2003-11-24 2005-05-25 Johnson & Johnson Medical Ltd Wound dressing for the controlled release of therapeutic agents comprising also an inhibitor of a protease enzyme & a linker group cleavable by such an enzyme
PL1789534T3 (pl) * 2004-08-16 2015-03-31 Cellresearch Corp Pte Ltd Wyodrębnienie komórek macierzystych/progenitorowych z błony owodniowej pępowiny
US20060222634A1 (en) * 2005-03-31 2006-10-05 Clarke Diana L Amnion-derived cell compositions, methods of making and uses thereof
US8153430B2 (en) * 2005-03-31 2012-04-10 Stemnion, Inc. Methods related to surgery
CN103356706B (zh) * 2005-03-31 2016-01-20 斯丹姆涅恩有限公司 促进无疤愈合或改善皮肤外观的美容制剂
EP1910541B1 (en) * 2005-06-16 2010-10-20 Wisconsin Alumni Research Foundation Cytotoxic ribonuclease variants
AU2006259408A1 (en) * 2005-06-17 2006-12-28 Genentech, Inc. Use of VEGF for wound healing
DK1764372T3 (da) * 2005-09-20 2009-11-30 Peter Jon Nelson Vævsinhibitor af metalloproteinaser (TIMP) bundet til glycosylphosphatidylinositol (GPI)-ankre til behandling af cancer
US8871198B2 (en) * 2006-03-29 2014-10-28 Stemnion, Inc. Methods related to wound healing
US8475788B2 (en) * 2006-06-14 2013-07-02 Stemnion, Inc. Methods of treating spinal cord injury and minimizing scarring
WO2007145889A1 (en) * 2006-06-14 2007-12-21 Stemnion, Inc. Methods of treating spinal cord injury and minimizing scarring
EP2139497B1 (en) * 2007-04-13 2013-11-06 Stemnion, INC. Methods for treating nervous system injury and disease
US20090004161A1 (en) * 2007-06-26 2009-01-01 Palladino Linda O Methods for treating pustular conditions of the skin
US20090054339A1 (en) * 2007-08-22 2009-02-26 Marshall Vivienne S Novel cellular factor-containing solution compositions

Also Published As

Publication number Publication date
CN101815531A (zh) 2010-08-25
US20130302307A1 (en) 2013-11-14
US8058066B2 (en) 2011-11-15
US20120322731A1 (en) 2012-12-20
US20120101036A1 (en) 2012-04-26
US20120238495A1 (en) 2012-09-20
US8198239B2 (en) 2012-06-12
EP2185197B1 (en) 2018-10-17
CA2696877A1 (en) 2009-02-26
US8283316B2 (en) 2012-10-09
US20150025007A1 (en) 2015-01-22
US8278417B2 (en) 2012-10-02
EP2185197A1 (en) 2010-05-19
WO2009025730A1 (en) 2009-02-26
US20090054339A1 (en) 2009-02-26
TR201815580T4 (tr) 2018-11-21
US9173927B2 (en) 2015-11-03
ES2702809T3 (es) 2019-03-05
US20120225815A1 (en) 2012-09-06
US20100075905A1 (en) 2010-03-25
CN101815531B (zh) 2015-01-14
US8088732B2 (en) 2012-01-03
US20100144604A1 (en) 2010-06-10
US8318672B2 (en) 2012-11-27
US20130040880A1 (en) 2013-02-14
CN104623669A (zh) 2015-05-20
JP2010536851A (ja) 2010-12-02
US8530418B2 (en) 2013-09-10
EP2185197A4 (en) 2011-11-23
CY1120994T1 (el) 2019-12-11
US8822415B2 (en) 2014-09-02
US20120225048A1 (en) 2012-09-06
DK2185197T3 (en) 2018-12-10
US8318665B1 (en) 2012-11-27

Similar Documents

Publication Publication Date Title
PT2185197T (pt) Novas composições de solução contendo fator celular e sua utilização para o tratamento de feridas
HUS2300001I1 (hu) Készítmények és alkalmazások szklerózis multiplex kezelésére
PL2200431T3 (pl) Nowe kompozycje i metody służące leczeniu raka
EP2078522A4 (en) COMPOSITION FOR THE TREATMENT OF ALLERGIES
EP2121110A4 (en) BIOKOMPATIBLE WUNDAUFLAGE
EP2314278A4 (en) HAIR TREATMENT COMPOSITION
GB0723874D0 (en) Dressing
IL202015A0 (en) Methods and compositions for treating skin conditions
PL2303209T3 (pl) Stabilizator kolana
EP2617721A4 (en) NEW HETEROCYCLIC COMPOUND AND COMPOSITION FOR THE TREATMENT OF INFLAMMATORY DISORDERS THEREWITH
IL202256A0 (en) Tissue fragment composition for the treatment of incontinence
EP2120561A4 (en) COMPOSITIONS FOR TREATING BIOFILMS, AND METHODS FOR THEIR USE
EP3117842C0 (en) FABRIC DRESSING MATERIAL
IL209336A0 (en) Compositions for treating hyperproliferative diseases and uses thereof
GB0813040D0 (en) Compositions for use as or in wound dressings
PL2209458T3 (pl) Kompozycje do traktowania skóry
IL219439A0 (en) Composition for promoting wound healing
TWI367274B (en) Composition for fabric treatment
GB0705923D0 (en) Dressing
IL211904A0 (en) Composition for treating disese
ZA201105125B (en) Hair treatment composition
EP2134337A4 (en) NOVEL COMPOSITION FOR TREATING BURNS
PL2124793T3 (pl) Urządzenie do leczenia ran
EP2019819A4 (en) INNOVATIVE PEPTIDE DERIVATIVES AS ANTIMICROBIAL AGENTS FOR THE TREATMENT OF INJURIES
IL208624A0 (en) Compositions for the treatment of lice